Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells.

Cell Signal

Basic Research Laboratory, Center for Cancer Research, National Cancer Institute-Frederick, Building 567, Room 226, Frederick MD 21702, USA.

Published: January 2005

AI Article Synopsis

  • SCF activates multiple signaling pathways by inducing autophosphorylation of Kit and influencing components like Jnks, Erks, and the JAK-Stat pathway.
  • Lyn, a Src family member, plays a crucial role in SCF-mediated cell growth and signaling, with studies using Lyn-deficient bone marrow mast cells revealing reduced phosphorylation of Kit and Jnks compared to wild-type cells.
  • Interestingly, although Lyn-deficient cells show increased Kit surface expression, they have impaired SCF-induced activation of certain pathways like Jnks and Stat3, while Lyn seems to negatively regulate the PI 3 Kinase/Akt pathway, leading to complex effects on cell signaling.

Article Abstract

SCF induces autophosphorylation of Kit and activates a variety of signaling components including Jnks, Erks, PI 3 Kinase, the JAK-Stat pathway and members of the Src family. Previously we showed that Lyn is activated at multiple points during SCF-induced cell cycle progression and contributes to SCF-mediated growth, chemotaxis and internalization of Kit. However, the Kit-dependent biochemical events that require Lyn are unknown. In this study, we used Lyn-deficient bone marrow mast cells (BMMC) to examine the contribution of this Src family member to tyrosine phosphorylation of Kit and SCF-induced activation of Jnks, Akt, Stat3 and Erks. Although surface expression of Kit was increased in Lyn-deficient BMMC, SCF-induced phosphorylation and growth was reduced compared to wild-type BMMC. Downstream of Kit, SCF-induced activation of Jnks was markedly reduced in Lyn-deficient BMMC. Further, Lyn was required for SCF-induced tyrosine phosphorylation of Stat3. Interestingly, Kit was constitutively associated with PI 3 Kinase in Lyn-deficient BMMC and this correlated with constitutive phosphorylation of Akt. This was in marked contrast to wild-type BMMC, where both these events were induced by SCF. These data indicate that in BMMC, Lyn contributes to SCF-induced phosphorylation of Kit, as well as phosphorylation of Jnks and Stat3. In contrast, Lyn may negatively regulate the PI 3 Kinase/Akt pathway. The opposing effects of Lyn on these signaling pathways may explain the pleiotropic effects ascribed to this Src family member in the literature.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellsig.2004.06.004DOI Listing

Publication Analysis

Top Keywords

src family
12
lyn-deficient bmmc
12
lyn contributes
8
signaling pathways
8
bone marrow
8
marrow mast
8
mast cells
8
family member
8
tyrosine phosphorylation
8
phosphorylation kit
8

Similar Publications

Overexpression of the myeloid Src-family kinases Fgr and Hck has been linked to the development of acute myeloid leukemia (AML). Here we characterized the contribution of active forms of these kinases to AML cell cytokine dependence, inhibitor sensitivity, and AML cell engraftment in vivo. The human TF-1 erythroleukemia cell line was used as a model system as it does not express endogenous Hck or Fgr.

View Article and Find Full Text PDF

Schlemm's canal endothelial cells (SECs) serve as the final barrier to aqueous humor (AQH) drainage from the eye. SECs adjust permeability to AQH outflow to modulate intraocular pressure (IOP). The broad identification of IOP-related genes implicates SECs in glaucoma.

View Article and Find Full Text PDF

Fibrosis results from excessive extracellular matrix (ECM) deposition, causing tissue stiffening and organ dysfunction. Activated fibroblasts, central to fibrosis, exhibit increased migration, proliferation, contraction, and ECM production. However, it remains unclear if the same fibroblast performs all of the processes that fall under the umbrella term of "activation".

View Article and Find Full Text PDF

Research progress of SHP-1 agonists as a strategy for tumor therapy.

Mol Divers

December 2024

Shenzhen Key Laboratory of Viral Oncology, Ministry of Science and Innovation, ShenZhen Hospital, Southern Medical University, Shenzhen, 518000, People's Republic of China.

Src homology-2 domain-containing protein tyrosine phosphatase 1 (SHP-1) is a member of protein tyrosine phosphatase (PTP) family, and serves as a crucial negative regulator of various oncogenic signaling pathways. The development of SHP-1 agonists has garnered extensive research attention and is considered as a promising strategy for treating tumors. In this review, we comprehensively analyze the advancements of SHP-1 agonists, focusing on their structures and biological activities.

View Article and Find Full Text PDF

Background/aim: Lung cancer, a predominant contributor to cancer mortality, is characterized by diverse etiological factors, including tobacco smoking and genetic susceptibilities. Despite advancements, particularly in nonsmall-cell lung cancer (NSCLC), therapeutic options for lung squamous cell carcinoma (LUSC) are limited. Transposable elements (TEs) and their regulatory proteins, such as tigger transposable element derived (TIGD) family proteins, have been implicated in cancer development.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!